Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by TOCATon Aug 28, 2013 12:51pm

366 Views

Post# 21703695

News by Sept 29,2013

It appears that Dr. Shapiro will share some information on the cell pouch transplants at a meeting of the American Academy of Family Physicians Aug 24 to Aug 29 2013 in San Diego. If he does, then we will have the first results of the cell pouch in human trials. We know we have at least one patient who has had the transplant for more than 1 year. I don't know why there is no speculation in the company with results coming in one month. Hopefully results are good.

Bullboard Posts

High Tide adds two stores to undervalued cannabis retail network